Article
A transposon-based strategy to scale up myxothiazol production in myxobacterial cell factories.
Journal of biotechnology - 30 Jun 2008
Sandmann A, Frank B, Müller R
Abstract excerpt
Myxobacteria are proficient producers of biologically active secondary metabolites. However, efforts to exploit these natural products for the development of new therapeutics and agrochemicals are frequently hampered by low production levels. We describe here a transposon-based strategy to identify genes encoding regulators of secondary metabolite biosynthesis in the myxobacterium Angiococcus disciformis An d48,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
